Economy
Not only is the ISM Manufacturing headline number rebounding, but the Prices Paid component is also strengthening. Together, these indicators imply that the deflationary bust that engulfed the US economy last summer is toward its tail end. Historically,…
Yesterday, BCA's US Investment Strategy service continued its analysis into the potential for labor unions to make a comeback. Globalization has squeezed unskilled labor everywhere in the developed world. Now, white-collar workers are becoming increasingly…
Highlights Portfolio Strategy China’s monetary easing, the resilient US dollar, weak operating industry metrics and a looming margin squeeze all signal that an underweight stance is still warranted in the S&P chemicals index. Lofty valuations, overbought technicals, declining capex and weak operating metrics, are all warning that an earnings-led underperformance period is in store for the S&P tech hardware, storage & peripherals index. Recent Changes Trim the S&P tech hardware, storage & peripherals index to underweight, today. Table 1 Feature The S&P 500 fell for a second straight week and has now given back almost all of the year-to-date gains. While the coronavirus has served as an excuse to sell as we warned last week,1 we are nowhere near in unwinding the extreme overbought conditions in the broad equity market. We are no epidemiology experts, however, what concerns us most is when the news will eventually hit that coronavirus deaths are sprucing up outside of China’s borders. This will likely catalyze more equity selling and a capitulation point will subsequently ensue. Importantly, beneath the surface macro divergences remain wide. The yield curve peaked at the turn of the year. Similarly, the real 10-year Treasury yield crested around the same time and so did the hyper growth sensitive AUD/CHF cross rate all predating the coronavirus epidemic news (Chart 1). Our sense is that the bond market in particular is likely reflecting Bernie Sander’s rise in the polls along with persistently soft economic data. Other indicators we track confirm that the handoff from liquidity-to-growth we have all been waiting for remains on hold. The oil-to-gold and copper-to-gold ratios have no pulse, warning that growth remains elusive (third & bottom panels, Chart 2). Chart 1Souring Macro Predates Coronavirus Chart 2Watch Gold Closely Moreover, in our January 13 report we highlighted that gold was sniffing out two or three fed cuts in 2020, leading the fed funds futures market, as it did in the spring of 2019.2 Since our last update, the fed funds discounter in the coming 12 months has sunk from negative 20bps to negative 42bps (year-on-year change in the fed funds rate shown inverted, second panel, Chart 2). It is disconcerting that despite the sloshing liquidity and de-escalation in the US/China trade war, CEOs remain on the sidelines. The Q4 GDP release showed that non-residential investment is now contracting on a year-over-year (yoy) basis (bottom panel, Chart 3) and has been subtracting from real output growth for three consecutive quarters. Hard data continues to warn that the manufacturing recession is not over as the 15% yoy contraction in non-defense durable goods orders revealed last week (third panel, Chart 3). Equity market internals also warn that the SPX is skating on thin ice. Worrisomely, the Philly semiconductors index (SOX) peaked versus the NASDAQ 100 last year and has been losing steam of late. The equally- versus market cap-weighted S&P 500 and NASDAQ 100 ratios remain near multi-year lows, and small caps are still stalling versus large caps (Chart 4). The implication is that, at least, an indigestion period looms for the broad equity market. Chart 3Ongoing Manufacturing Recession Chart 4Weak Market Internals Netting it all out, there are high odds that the coronavirus epidemic may serve as a catalyst and short-circuit the already frail handoff from liquidity-to-growth, warning that equity market caution is warranted at this juncture. This week we are trimming a key tech subgroup to underweight, and updating a heavyweight basic materials sub-index. To Infinity And Beyond? While we have been neutral the S&P tech hardware, storage & peripherals index and thus participating in the monster rally over the past year, the time is ripe to downgrade exposure to below benchmark. Undoubtedly, relative share prices are extremely extended. The second panel of Chart 5 shows that the relative share price ratio is at the highest level as a percentage of its 200-day moving average since the late-1990s. Shown as a z-score, this technical indicator is stretched to the tune of two standard deviations above the historical mean (third panel, Chart 5). The last three times technical conditions were so overbought, it marked a multi-year peak in relative performance (top panel, Chart 5). Importantly, the forward multiple explains all of the return in this tech sub-group’s stellar relative performance since the 2018 Christmas Eve lows (Chart 6). In fact, stagnant-to-lower relative profit growth subtracted from relative returns over the same time period (bottom panel, Chart 6). Chart 5Up, Up And Away? Moreover, the parabolic move in the forward P/E ratio that climbed from a 25% discount to the SPX to a 15% premium (i.e. a 53% multiple jump), was because the 10-year US Treasury yield plunged by 175 basis points from peak to trough (10-year US Treasury yield shown inverted, Chart 7). Chart 6EPS Have To Do The Heavy Lifting Chart 7Multiple Expansion Phase Has Run Its Course Such enormous easing in financial conditions is unlikely to repeat in the coming twelve months in order to push the forward multiple even higher and sustain the “goldilocks” conditions for the S&P tech hardware, storage & peripherals index. In contrast, BCA’s higher interest rate view is a harbinger of a multiple contraction phase and compels us to trim exposure on this high-flying tech sub group to underweight. Another market narrative substantiating the multiple expansion phase is that heavyweight AAPL is now a services oriented company and rightly so commands a sky-high multiple similar to the cloud and software stocks. While there is some truth to the push into services, the iphone and other hardware still dominates AAPL’s sales and will continue to do so for the foreseeable future especially on the eve of a 5G smartphone rollout. Turning over to the macro backdrop, this still mostly manufacturing-based industry moves with the ebbs and flows of the ISM manufacturing survey. Overall business investment is contracting and so is industry capex. Worrisomely, most of the ISM manufacturing subcomponents remain below the boom/bust line warning that investment will remain soft in the coming months, despite the Sino-American trade détente (middle panel, Chart 8). CEO confidence in capital spending remains downbeat and corroborates that at least a wait and see attitude toward greenfield expansion plans is a high probability outcome (bottom panel, Chart 8). Moreover, global export expectations continue to plumb cyclical lows. Similarly, the Emerging Asian (a key tech manufacturing hub) leading economic indicator broke below the GFC lows warning that industry exports are at risk of a further collapse (second & third panels, Chart 9). Chart 8Something’s Gotta Give Chart 9Weak Operating Metrics Chart 10Soft Pricing Power… Chart 11…Will Continue To Weigh On Margins Beyond soft exports, industry new orders are also contracting (bottom panel, Chart 9). This deficient demand backdrop will continue to weigh on industry sales, owing to the recent drubbing in pricing power (third panel, Chart 10).\ Deflating selling prices are also negative for profit margins. The wide gap between industry and SPX margins is clearly unsustainable (Chart 11). Already there is tentative evidence that S&P tech hardware, storage & peripherals margins have peaked and will remain under downward pressure, especially given our expectation of underwhelming profit growth in the coming months. In sum, lofty valuations, overbought technicals, declining capex and weak operating metrics are all warning that an earnings-led underperformance period is in store for the S&P tech hardware, storage & peripherals index. Nevertheless, there is one risk that is worth monitoring: the US consumer. A tight labor market should continue to bid up the price of labor and sustains wage gains which means more money in consumers’ wallets. As a result, brisk consumer outlays on computers & peripherals could reverse the ongoing industry sales deceleration (bottom panel, Chart 12). In sum, lofty valuations, overbought technicals, declining capex and weak operating metrics are all warning that an earnings-led underperformance period is in store for the S&P tech hardware, storage & peripherals index. Bottom Line: Downgrade the S&P tech hardware, storage & peripherals index. The ticker symbols for the stocks in this index are: BLBG S5CMPE – AAPL, HPQ, WDC, HPE, STX, NTAP, XRX. Chart 12Risk To Bearish View Hazardous Chemicals The S&P chemicals bear market has entered its third year and we remain underweight this capital intensive basic materials subgroup. Relative share prices have broken below the GFC lows and it would not surprise us if they would retest the 2006 lows (Chart 13). Now that the chemicals M&A activity dust has settled for good, China dominates the direction of chemical equities. Chinese authorities are still easing monetary policy and are injecting liquidity in the banking system by slashing the reserve requirement ratio (RRR). The recent coronavirus epidemic almost guarantees further easing via the RRR channel. Such a monetary setting should eventually stabilize the economy. However, until a turnaround is evident, US chemical stocks will continue to follow down the path of the Chinese RRR (top panel, Chart 13). The Australian currency, which is hyper-sensitive to China’s growth, corroborates that Chinese economic activity remains soft (second panel, Chart 13). Broad-based US dollar strength also confirms that global growth has yet to stage a durable comeback. The implication is that US chemical exports will continue to lose market share, weighing on industry profits (third panel, Chart 13). Chart 13China Leads The Way In fact, sell-side analysts are expecting a relative profit growth acceleration phase, but a decline in relative revenue prospects. This suggests that already uncharacteristically high chemical profit margins will continue to outpace the broad market (bottom panel, Chart 13). Our indicators suggest that it pays to lean against such relative EPS and profit margin euphoria. Importantly, our chemicals profit margin proxy is sinking, warning that a profit margin squeeze looms. Not only are selling prices deflating, but also the industry’s wage bill is gaining steam (bottom panel, Chart 14). Adding it up, China’s monetary easing, the resilient US dollar, weak operating industry metrics and a looming margin squeeze all signal that an underweight stance is still warranted in the S&P chemicals index. Moreover, chemical railcar loads are contracting at a time when the ISM manufacturing survey remains squarely below the boom/bust line (middle panel, Chart 14). This deficient chemical demand backdrop is deflationary (second panel, Chart 15) and will eat into industry profit margins. Chart 14Downbeat Demand Backdrop Chart 15Deflation Getting Entrenched On the operating front, our chemicals industry productivity proxy (industrial production/employment) is also in negative territory, underscoring that profits will likely surprise to the downside (third panel, Chart 15). Chemical industrial production is contracting at an accelerating pace and industry shipments are in retreat, warnings that the risk is high of an inventory liquidation phase (bottom panel, Chart 15). While we remain bearish on chemical stocks on a cyclical horizon, there are two key risks we are closely monitoring that would push our view offside. The global reflation handoff to actual growth is the key risk. If the global economy enters a V-shaped recovery, global bond yields will immediately reflect such a growth backdrop and push interest rates higher. This would put downward pressure on the greenback and significantly reflate chemical earnings (middle panel, Chart 16). Finally, chemical stocks are cheap and trade at a steep discount to the broad market. When our relative valuation indicator has plunged to such depressed levels in the past fifteen years, bottom-fishing buyers have come back in the market and added chemical stock exposure to their portfolios (bottom panel, Chart 16). Adding it up, China’s monetary easing, the resilient US dollar, weak operating industry metrics and a looming margin squeeze all signal that an underweight stance is still warranted in the S&P chemicals index. Bottom Line: Stay underweight the S&P chemicals index. The ticker symbols for the stocks in this index are: BLBG S5CHEM – LIN, APD, ECL, SHW, DD, DOW, PPG, CTVA, LYB, IFF, CE, FMC, EMN, CF, ALB, MOS. Chart 16Two Risks To Monitor Anastasios Avgeriou US Equity Strategist anastasios@bcaresearch.com Footnotes 1 Please see BCA US Equity Strategy Weekly Report, “When The Music Stops...” dated January 27, 2020, available at uses.bcaresearch.com. 2 Please see BCA US Equity Strategy Weekly Report, “Three EPS Scenarios” dated January 13, 2020, available at uses.bcaresearch.com. Current Recommendations Current Trades Size And Style Views Stay neutral cyclicals over defensives (downgrade alert) Favor value over growth Favor large over small caps (Stop 10%)
10-year Treasury yields are once again trading near 1.47%, their September lows. Compared to then, the near-term trade risks have abated, the Chinese economy has stabilized, and Asia is picking up. Moreover, US CEO confidence and the German ZEW survey have…
The S&P 500 experienced a second week of heavy declines as the WHO declared 2019-nCoV a global emergency. BCA has argued that the spreading virus is a catalyst that crystalized the risk to stocks created by extremely overextended equity markets. In this…
Asia’s economic recovery is broadening, as evidenced by the rebound in the region’s Economic Diffusion Index. Obviously, the outbreak of 2019-nCoV will delay the full blossoming of this trend, but the underlying economic improvement in Asia seems real. Since…
Last Friday, BCA’s Global Investment Strategy service wrote that beyond their anticipation of stronger global growth for 2020, another factor is supporting stocks: corporate buybacks. The combination of copious buybacks and dearth of IPOs has caused the…
Highlights The SARS episode of 2003 suggests that the panic over the coronavirus will only subside when the number of new cases peaks. Although the latest data is somewhat encouraging, it is far from clear that we have reached that point. Provided the outbreak is contained, global equities should move higher over the course of the year. US companies remain net buyers of shares, implying that households and other holders have been net sellers. But against a backdrop of rising incomes, high savings, and improving confidence, households have also wanted to own more equities. How can households be net sellers of stocks while simultaneously increasing their equity exposure? There is only one answer: Share prices need to rise. The process will only stop once households decide they own enough stocks. In the US, while household equity holdings are on the high side as a share of household wealth, this is counterbalanced by the fact that the earnings yield on stocks is well above the yields on competing assets. Outside the US, household ownership of equities is quite low while the equity risk premium is still high. Going Viral We upgraded global equities after markets plunged in late 2018 and have remained overweight stocks on a 12-month horizon to this day. However, we indicated three weeks ago that equities had become technically overbought and would likely need to consolidate their gains. Thus, while we kept our 12-month views unchanged, we downgraded our tactical 3-month view on global stocks from overweight to neutral, while also advising clients with short horizons to boost exposure to cash and government bonds at the expense of riskier credit (our entire set of views can be found in the Global Investment Strategy View Matrix at the back of this report). Since then, the outbreak of the coronavirus has added another headwind to the near-term outlook for stocks. Many commentators have drawn comparisons between today’s outbreak and the SARS epidemic in 2003. The SARS episode imposed a significant but short-lived economic toll on the affected countries. While Chinese GDP growth fell to 3.4% in Q2 of 2003, it surged back to 15.7% in Q3, leaving the overall level of GDP down about 1% for the year as a whole relative to what would have transpired if the virus had never emerged.1 The broader Asia-Pacific region experienced a hit to growth of around 0.5%. In contrast, growth in developed economies was barely affected. Even in Canada, where 44 people died from SARS, the outbreak shaved only around 0.1% from the level of GDP in 2003, according to the Bank of Canada.2 The outbreak of the coronavirus has added another headwind to the near-term outlook for stocks. The obvious problem with the SARS analogy is that it is based on a sample of one. We do not know how this new strain of the virus compares to SARS or, for that matter, the Spanish flu, which killed 50-to-100 million people (3%-to-5% of the world’s population at the time). We do not even know if the full scope of the SARS outbreak was as fleeting as what we remember, since in a cosmic multiverse there will be a tendency to recall life-or-death outcomes more favorably than they actually were (I will have more to say about the financial implications of this in a future special report). Chart 1The Coronavirus Is Spreading Faster Than SARS Did What we do know is that, to date, the coronavirus has spread more quickly than SARS (Chart 1). It is not clear if that is because of faster, more accurate reporting methods or because the virus is more communicable. The Chinese Minister of Health has said that this new virus, unlike SARS, can be transmitted while people are still asymptomatic. While others have cast doubt on this claim, if it turns out to be correct, the coronavirus may be much more difficult to control. Viruses often become less lethal as they mutate because a virus that kills its host is also a virus that kills itself. Unfortunately, in a world of mass travel, a virus can spread across the globe before it has time to lose potency. The typical seasonal flu kills less than 0.1% of those who contract it. Most estimates suggest that SARS killed 10%-15% of infected patients. The Spanish flu killed a similar percentage. The death rate from the coronavirus is currently tracking at 2%-to-3%. However, it is possible that this estimate will rise. The vast majority of the people who have contracted the coronavirus are still sick. In fact, more people have died from it than have fully recovered (Chart 2). Thus, an honest assessment would simply admit that we do not know how bad this potential pandemic will get. Chart 2How Will This End: Outbreak, Epidemic, Or Pandemic? Chart 3Markets Bottomed As The SARS Infection Rate Was Peaking What should investors do? The SARS experience suggests that risk assets will only bottom when the number of new cases peaks (Chart 3). It is not clear that we have reached this point yet. While the number of new cases reported by China’s National Health Commission has stabilized over the past two days, this could just be a temporary respite (Chart 4). Until the rate at which new cases are diagnosed begins a clear downward trend, a somewhat cautious stance towards risk assets is warranted. Global Growth Should Recover Provided the outbreak is contained during the coming weeks, global equities should move higher over the course of the year. This is partly because global growth should pick up thanks to the lagged effects of last year’s decline in bond yields, an improvement in the global manufacturing inventory cycle, and diminished Brexit and trade war risks. Continued fiscal/credit stimulus out of China should also help. China spends less on health care than almost all other countries (Chart 5). It is likely that the past few weeks will prompt the government to increase social spending. Chart 4The Number Of New Cases Has Stagnated Over The Past Two Days Chart 5China: Public Spending On Health Care Has Room To Catch Up Higher Equity Prices: Just A Matter Of Arithmetic? Chart 6There Is A Structural Decline In Listed Companies In The US Chart 7The Supply Of US Stocks Has Been Drying Up In addition to stronger global growth, there is another factor supporting stocks which receives insufficient attention and is worth highlighting in this week’s report: corporate buybacks. US companies have repurchased about 3% of their shares every year for the past decade. On the flipside, only 110 companies went public last year, less than a third of the number of new listings in 1996-99. In fact, the number of publicly traded domestic companies has fallen by over 40% since 1996 (Chart 6). The combination of copious buybacks and dearth of IPOs has caused the S&P divisor – a broad measure of the total number of split-adjusted shares outstanding – to decline by a cumulative 9% since 2011. Between 1990 and 2004, the divisor increased by 40% (Chart 7). If companies are net buyers of stocks, then households and other holders must be net sellers of stock. But this raises an obvious question: What if households also want to be net buyers of stocks? Chart 8Households Are Bullish Chart 9High Equity Ownership By Households Translates Into Poor Long-Term Returns This question is highly relevant in today’s environment, where unemployment is low, wage growth is accelerating, the household savings rate is high, consumer confidence is strong, and a higher-than-average percentage of people expect stocks to increase in the coming months (Chart 8). Arithmetically, there is only one way that households can be net sellers of stocks while simultaneously increasing their equity exposure: Share prices need to rise. At what point will share prices stop rising? That depends on two things: 1) How much stock market wealth households hold relative to other assets; and 2) The risk-adjusted rate of return that households expect from stocks compared to other assets. Stock returns are highest when equity holdings are low, but sentiment towards stocks is improving. Conversely, returns are lowest when equity holdings are high, but stock market sentiment is deteriorating (Chart 9 and Table 1). Table 1Equity Returns Tend To Suffer When Bulls Are Losing Conviction The latter typically occurs during economic downturns when earnings are falling and risk aversion is rising. Thus, it is no surprise that recessions and equity bear markets tend to overlap (Chart 10). Chart 10Recessions And Bear Markets Tend To Overlap Where Things Stand Today In the US, household equity holdings are on the high side. According to Fed data and our own estimates, households currently hold 33% of their financial assets in stocks (Chart 11). This is higher than in 2007, but still below the dotcom peak of 39%. Similarly, the monthly asset allocation survey conducted by the American Association of Individual Investors shows a somewhat elevated allocation to equities, although one that is still broadly on par with the 2003-2007 and post-2014 averages (Chart 12). Chart 11US Household Equity Holdings Are On The High Side (I) Chart 12US Household Equity Holdings Are On The High Side (II) Chart 13Relative Valuations Favor Stocks One major difference with prior occasions when US equity allocations were elevated is that the earnings yield on stocks at present is still quite a bit higher than the yield on competing assets such as cash and bonds (Chart 13). While this is mainly because interest rates are so low, it does suggest that households may seek to further increase their equity allocations provided that the economy continues to perform well. Foreign companies have been less aggressive re-purchasers of their own shares than their US peers. That said, household equity ownership is significantly lower outside the US (Chart 14). The spread between equity earnings yields and bond yields is also higher abroad, reflecting the fact that both PE multiples and interest rates are generally lower outside the US. Given that investors tend to favor companies listed in their home country, efforts by non-US investors to increase their equity allocations will primarily benefit stock markets outside the US. In addition, stronger global growth tends to favor EM and European equities, largely because stock markets in those regions have more of a cyclical bent (Chart 15). Thus, on balance, we recommend that investors overweight non-US stocks this year. Chart 14Equity Ownership By Households Is Lower Outside The US Chart 15Stronger Global Growth Tends To Favor A Cyclical Bias In Equity Allocation Peter Berezin Chief Global Strategist peterb@bcaresearch.com Footnotes 1 Jong-Wha Lee and Warwick J. McKibbin, “Globalization and Disease: The Case of SARS,” Brookings Institution, dated February 2004. 2 Please see Monetary Policy Report, Bank of Canada, October 2003. Global Investment Strategy View Matrix MacroQuant Model And Current Subjective Scores Strategic Recommendations Closed Trades
Next week, we will focus on the following key items: The spread of nCoV-2019: We will continue to monitor how the coronavirus is spreading, especially as a case of human-to-human transmission has been reported in the US. In all likelihood, this…

